|
| Exchange Disseminated Time | Kilitch Drugs India Ltd has informed BSE that the members at the 16th Annual General Meeting (AGM) of the Company held on September 22, 2008, inter alia, have accorded to the following:
1. Adoption of the audited Balance Sheet as at March 31, 2008 and the Profit and Loss Account for the year ending March 31, 2008 together with the Auditors Report and the Directors Report thereon along with the annexures thereto.
2. Confirmation of dividend at the rate of 10% per equity share capital of the Company of Rs 10 each for the year ended March 31, 2008.
3. Re-appointment of Mr. Mukund P Mehta & Mr. Mukesh Shah, as Directors of the Company, liable to retire by rotation.
4. Re-appointment of M/s. R S Negi & Co., Chartered Accountants, Mumbai as Auditors of the Company to hold office until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions.
5. Appointment of Mr. Nitin R Shah, Mr. Bhavin Mehta, Mr. Pankaj Kamdar, Dr. Mahalingam Vasudevan, Mr. Deepak Shenoy, Mr. Shailesh Chheda & Mr. Hemang Engineer, as Directors of the Company liable to retire by rotation.
6. Appointment of Mr. Nitin R Shah, as Whole time Director of the Company for a period of five years with effect from October 01, 2007 to September 30, 2012, on remuneration, terms & conditions. |
|
|